Sartorius Stedim Biotech (SSB) has introduced the new ambr® 15 fermentation system, an automated micro bioreactor system designed to enhance microbial strain screening with advanced capabilities ...
Morning Overview on MSN
New bioreactor makes 40M human macrophages a week from stem cells
A benchtop bioreactor system developed at Hannover Medical School can produce up to 40 million human immune cells per week ...
The BioXplorer 5000 is a lab-scale bioreactor platform available in sizes ranging from 1-5L and in high- and low-pressure variants. It can be utilized for a huge variety of applications, ranging from ...
Researchers at Hannover Medical School have developed a benchtop bioreactor system that can generate up to 40 million human macrophages per week from induced pluripotent stem cells. The medium-scale ...
Automated Control Concepts has launched Lab Owl bioreactor control system for labs using cell culture and fermentation applications. On Jan. 16, 2018, Automated Control Concepts (ACC), an independent ...
The ambr 250 is a mini bioreactor system for parallel fermentation or cell culture. On June 15, 2016, Sartorius Stedim Biotech introduced the ambr 250 mini benchtop bioreactor system for parallel ...
Despite the struggling economy, “the bioreactor/cell culture market remains relatively strong,” claims Mike Sattan, vp of marketing at New Brunswick Scientific (NBS), an Eppendorf company. The ...
The BioXplorer 400 has been fitted with four bioreactors along with working volumes of up to 400 mL. It is an ideal tool for parallel bioprocess optimization. The highly configurable nature of their ...
New York, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biopharmaceutical Fermentation System Market Research Report by Product, by Application, by End User - ...
Equipped with Unobtrusive Biosensors and Sophisticated Control Software, Bioreactors Are More Efficient Although single-use bioreactors are increasingly common in small-scale cell culture, many users ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results